| ZFIN ID: ZDB-EXP-250811-5 |
Experiment Conditions Description: lighting conditions, chemical treatment by environment: doxazosin
| lighting conditions |
|---|
| Name: | lighting conditions |
|---|---|
| Synonyms: | |
| Definition: | Experimental condition in which the intensity, wavelength, and/or duration of illumination is (are) different from the one in controlled conditions. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000146] |
| chemical treatment by environment: doxazosin |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | doxazosin |
|---|---|
| Synonyms: | 1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin, 1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin, 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine, Doxazosin, doxazosina, doxazosine, doxazosinum |
| Definition: | A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure. |
| Ontology: | ChEBI [CHEBI:4708] ( EBI ) |
| Publication: | Sveinsdóttir et al., 2022 |
|---|